The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Gallbladder disease risk with rapid weight loss

This is a generated summary. It shows the 9 most-liked posts from a topic of 64, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
RI
retention_indexTL2Analytical chemist17 Aug 2024#2

Two people in this thread mean different things by gallbladder disease risk and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to define it.

26 likes 23mo
AD
a.delgadoTL2 Solution14 Sep 2024#9

Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute benefit is largest in high-risk people.

It cost nothing to check and would have cost something not to.

25 likes 22mo
RJ
r.jhannsdttirTL3Regular8 Oct 2024#17

Where the gallbladder disease risk discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.

33 likes 22mo
MA
mi.almeidaTL222 Oct 2024 · edited#22

The bit of gallbladder disease risk that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.

33 likes 21mo
DN
d.nwosuTL22 Nov 2024#26

Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.

25 likes 21mo
SS
s.silvaTL210 Nov 2024 · edited#29
resistance_first, post #10: Everything in post #6 holds. The case it does not cover is the one I have. Reading back through the gallbladder disease risk threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems like a documentation gap rather than a knowledge gap. Go to post

Narrowing post #26, because the general version has more than one answer.

Gallbladder disease risk came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.

32 likes in reply to #10 21mo
DV
dr.villanuevaTL3Physician2 Dec 2024#38

Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute benefit is largest in high-risk people.

The claim is narrower than it sounds, and deliberately so.

31 likes 20mo
YA
y.adebayoTL225 Dec 2024#48

Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.

I am not the right person to answer the follow-up to this.

28 likes 19mo
OB
owen.bradyTL4 Moderator27 Jan 2025#63
h.amankwah, post #40: Adding the measurement that post #39 says would settle it. Small correction to my own earlier position on gallbladder disease risk. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely. Go to post

Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not independent variables.

I have separated what I observed from what I concluded, which does not always happen.

31 likes in reply to #40 18mo

Read the full topic (64 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Gastro-oesophageal reflux: improving or worsening?
The question in the title: Gastro-oesophageal reflux: improving or worsening? I will give what I have already checked below so nobody repeats it. Collecting what is known about gastro-oesophageal reflux in…
PMMNZDID+54 58 8.2k 1mo
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. I was wrong about obstructive sleep apnoea in a thread last spring and I would…
OBFATWAKMS+120 129 1.8k 13mo
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
DOJMKHBMCE 4 16k 12h
Osteoarthritis and mechanical versus metabolic improvement
Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about osteoarthritis and mechanical versus metabolic…
NANRFKLWDP+2 6 30k 12h
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Heart failure with preserved ejection keeps being re-asked here and I…
ITSGSRFVII+19 23 311 12d

Related topics — sharing the tags obstructive sleep apnoea, type 2 diabetes, chronic kidney disease

TopicParticipantsRepliesViewsActivity
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
EAASVBSDFW+17 22 4.5k 1d
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. I was wrong about obstructive sleep apnoea in a thread last spring and I would…
OBFATWAKMS+120 129 1.8k 13mo
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from
Semaglutide half-life: where the 165 to 184 hour figure comes from Writing it up because I had to work it out twice and would rather nobody else did. Putting the numbers in the first post, because a question…
ICNTLMSO+112 119 3.3k 11mo
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
SPDBOCASCN+4 8 43k 17mo
About the Sleep category
Sleep quality, apnoea, and the bidirectional relationship with metabolic health. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
JMTVDCKIW+1 5 92 4mo